BEIJING, SHANGHAI and BOSTON, Jan. 6, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets announced today that the data from a registrational clinical trial of its independently developed KRAS G12C inhibitor glecirasib has been...
Read More Details
Finally We wish PressBee provided you with enough information of ( The Registrational Clinical Data of Glecirasib was Published in Nature Medicine )
Also on site :
- Padres Release Jason Heyward
- UNHCR: 2.5M refugees need resettlement as US freezes program
- Adidas Has 'Sleek' $180 Running Shoes for Just $90, and Reviewers Say They Feel Like They’re 'Walking On Clouds'